Web2 de nov. de 2024 · Massive Bio has received investments totaling $18 million since its establishment. The company has 75 employees and partners with 26 pharmaceutical … Web26 de oct. de 2024 · Massive Bio’s Profile, Revenue and Employees. Massive Bio is a New York-based AI-driven platform that provides clinical trial matching and cancer analysis solutions for the biopharmaceutical industry. Massive Bio’s primary competitors include TrialJectory, Antidote, Oncoshot and 1 more.
AdhereTech and Massive Bio Announce AI-Enabled, Patient …
Web2 de jun. de 2024 · NEW YORK-- ( BUSINESS WIRE )-- Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial … Web22 de mar. de 2024 · NEW YORK – Massive Bio and NeoGenomics said Wednesday that they have formed a collaboration to accelerate oncology drug discovery by improving the identification and enrollment of cancer patients eligible for clinical trials. ... Breaking News 23andMe, Morehouse School of Medicine Team Up on Sickle Cell Carrier Awareness funeral home on sherbourne street
The April Issue of Massive Bio Magazine is Now Available
Web10 de nov. de 2024 · NEW YORK – Health technology firms Massive Bio and Azra AI on Thursday announced a partnership to add Massive's clinical trial matching capabilities to Azra's cancer identification platform. Azra's technology is used in more than 200 hospitals, the companies said in the announcement, to help clinicians more quickly process … Web18 de nov. de 2024 · Massive Bio, based in New York City, uses a proprietary artificial intelligence platform called SYNERGY-AI to match cancer patients to clinical trials. “This … Web29 de mar. de 2024 · NEW YORK, March 29, 2024 -- ( BUSINESS WIRE )--Massive Bio, which uses artificial intelligence and concierge service to match cancer patients to oncology clinical trials regardless of their... girl scouts in italy facts